Efficacy of CPX‐351, (cytarabine:daunorubicin) liposome injection, against acute lymphoblastic leukemia (ALL) xenograft models of the Pediatric Preclinical Testing Program

Publisher： John Wiley & Sons Inc

E-ISSN： 1545-5017|62|1|65-71

ISSN： 1545-5009

Source： PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol.62, Iss.1, 2015-01, pp. : 65-71

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The pediatric preclinical testing program: Description of models and early testing results

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 49, Iss. 7, 2007-12 ,pp. : 928-940

John Wiley & Sons Inc

Access to resources Recommend Favorite

Treatment and biology of pediatric acute lymphoblastic leukemia

By  

PEDIATRICS INTERNATIONAL, Vol. 60, Iss. 1, 2018-01 ,pp. : 4-12

John Wiley & Sons Inc

Access to resources Recommend Favorite

AAML0523: A report from the Children's Oncology Group on the efficacy of clofarabine in combination with cytarabine in pediatric patients with recurrent acute myeloid leukemia

By  

CANCER, Vol. 120, Iss. 16, 2014-08 ,pp. : 2482-2489

John Wiley & Sons Inc

Access to resources Recommend Favorite

Considerations in the design of clinical trials for pediatric acute lymphoblastic leukemia

By Devidas Meenakshi   Anderson James R  

Clinical Investigation, Vol. 3, Iss. 9, 2013-09 ,pp. : 849-858

Future Science

Access to resources Recommend Favorite

Future perspectives on minimizing bone density reduction in pediatric acute lymphoblastic leukemia

By Winkel Mariël Lizet te   Pieters Rob   van den Heuvel-Eibrink Marry M  

Personalized Medicine, Vol. 7, Iss. 5, 2010-09 ,pp. : 469-471

Future Medicine

Access to resources Recommend Favorite